Towards evidence-based medicine in specific grass pollen immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 4, 2010, Pages 420-434

  Calderon, M ^a   Mosges R ^b   Hellmich, M ^b   Demoly, P ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Evidence based medicine; Grass pollen; Specific immunotherapy; Subcutaneous; Sublingual

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; GRASS POLLEN EXTRACT; GRASS POLLEN VACCINE; ORALAIR; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; ASTHMA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSPNEA; EDEMA; EMBASE; EVIDENCE BASED MEDICINE; GRASS POLLEN; HAY FEVER; HUMAN; IMMUNOTHERAPY; LOW DRUG DOSE; MEDLINE; MOUTH DISEASE; NAUSEA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHLEUM PRATENSE; POACEAE; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINITIS; RHINOCONJUNCTIVITIS; SAFETY; SEASONAL VARIATION; TABLET; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URTICARIA; UVULA EDEMA;

ADMINISTRATION, SUBLINGUAL; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; PLANT EXTRACTS; POACEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, SEASONAL;

EID: 77649220028     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02292.x     Document Type: Review

References (62)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 63 (Suppl 86 8 160.
2. Bousquet J, Annesi-Maesano I, Carat F, Léger D, Rugina M, Pribil C et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005 35 : 728 732.
3. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004 24 : 758 764.
4. Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D. European Community Respiratory Health Survey I Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007 62 : 301 309.
5. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. London, UK, Nov 2008 Draft CHMP/EWP/18504/2006. Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMEA). Accessed at http://www.emea.europa.eu/ pdfs/human/ewp/1850406enfin.pdf on 20 January 2008.
6. Allergic rhinitis: clinical development programs for drug products. Guidance for Industry. Beltsville, MD, April 2000. Center for Drug Evaluation and Research (CDER). Accessed at http://www.fda.gov/cder/guidance/index.htm on 15 January 2008.
7. Sackett DJ, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996 312 : 71 72.
8. Akobeng AK. Principles of evidence based medicine. Arch Dis Child 2005 90 : 837 840.
9. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
10. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006 97 : 141 148.
11. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 1 : CD001936.
12. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006 117 : 1021 1035.
13. Cox LS. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations. Curr Allergy Asthma Rep 2007 7 : 410 420.
14. Röder E, Berger MY, de Groot H, Gerth van Wijk R. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2008 19 : 197 207.
15. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991 21 : 77 83.
16. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997 99 : S742 S749.
17. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991 302 : 265 269.
18. Zenner HP, Baumgarten C, Rasp G, Fuchs T, Kunkel G, Hauswald B et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 1997 100 : 23 29.
19. Leynadier F, Banoun L, Dollois B, Terrier P, Epstein M, Guinnepain MT et al. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2001 31 : 988 996.
20. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 319 325.
21. Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996 51 : 489 500.
22. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999 341 : 468 475.
23. Walker SM, Pajno GB, Torres Lima M, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001 107 : 87 93.
24. Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001 56 : 498 505.
25. Brewczynski PZ, Kroon AM. Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study (Wirksamkeit und vertraglichkeit einer immuntherapie mit modifizierten graserpollenallergenen). Allergologie 1999 22 : 411 420.
26. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005 60 : 801 807.
27. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994 49 : 309 313.
28. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995 23 : 224 230.
29. Clavel R, Bousquet J, Andre C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998 53 : 493 498.
30. Hordijk GJ, Antvelink JB, Luwema RA. Sublingual immunotherapy with a standardised grass pollen extract;a double-blind placebo-controlled study. Allergol Immunopathol (Madr) 1998 26 : 234 240.
31. Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999 54 : 819 828.
32. de Blay F, Barnig C, Kanny G, Purohit A, Leynadier F, Tunon de Lara JM et al. Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2007 99 : 453 461.
33. Mösges R, Brüning H, Hessler HJ, Götz G, Knaussmann HG. Sublingual immunotherapy in pollen-induced seasonal rhinitis and conjunctivitis: a randomized controlled trial. Acta Dermatovenerol Alp Panonica Adriat 2007 16 : 143 148.
34. Torres Lima M, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002 32 : 507 514.
35. Smith H, White P, Annila I, Poole J, André C, Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004 114 : 831 837.
36. Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. Allerg Immunol (Paris) 2006 38 : 355 360.
37. Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009 64 : 179 186.
38. Yuksel H, Tanac R, Gousseinov A, Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. J Investig Allergol Clin Immunol 1999 9 : 305 313.
39. Wuthrich B, Bucher C, Jorg W, Bircher A, Eng P, Schneider Y et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003 13 : 145 148.
40. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 59 : 498 504.
41. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 59 : 1285 1293.
42. Röder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007 119 : 892 898.
43. Palma-Carlos A, Santos A, Branco-Ferreira M, Pregal A, Palma-Carlos M, Bruno M et al. Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study. Allergol Immunopathol 2006 34 : 194 198.
44. Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000 55 : 1142 1147.
45. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 802 809.
46. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 118 : 434 440.
47. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007 120 : 1338 1345.
48. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008 121 : 512 518. e2.
49. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009 123 : 160 166. e3.
50. Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009 123 : 167 173. e7.
51. Bousquet J, Hejjaoui A, Skassa-Brociek W, Guerin B, Maasch HJ, Dhivert H et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol 1987 80 : 591 598.
52. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass pollen allergoids. II Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988 82 : 439 446.
53. Bousquet J, Maasch HJ, Hejjaoui A, Skassa-Brociek W, Wahl R, Dhivert H et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989 84 : 546 556.
54. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990 85 : 490 497.
55. Pastorello EA, Pravettoni V, Incorvaia C, Mambretti M, Franck E, Wahl R et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992 47 : 281 290.
56. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005 116 : 608 613.
57. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006 117 : 263 268.
58. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT-study. Allergy 2007 62 : 943 948.
59. Verhagen AP, De Vet HCW, De Bie RA, Kessels AGH, Boers M, Bouter LM et al. The Delphi List: a criteria list of quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998 51 : 1235 1241.
60. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996 17 : 1 12.
61. Durham SR. Sublingual immunotherapy: what have we learnt from the 'big trials'? Curr Opin Allergy Clin Immunol 2008 8 : 577 584.
62. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008 336 : 924 926. (Pubitemid 351632017)